Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1133/week)
    • Manufacturing(603/week)
    • Technology(1091/week)
    • Energy(452/week)
    • Other Manufacturing(400/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Prime Therapeutics LLC

Jun 25, 2025
Prime Therapeutics' leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years
Oct 24, 2024
Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity
Oct 15, 2024
Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report(TM) goes behind the numbers
Oct 10, 2024
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Oct 07, 2024
Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice
Oct 03, 2024
Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance
Sep 12, 2024
Prime/Magellan Rx's Advocate+(TM) elevates specialty pharmacy experience, simplifies health care journey
Sep 06, 2024
Prime Therapeutics recognized at PBMI for award-winning solutions, leaders
Jun 19, 2024
Prime/MRx's new Pharmacy Match technology-driven solution expands specialty pharmacy access and choice
Jun 10, 2024
Prime Therapeutics hires industry veteran Mike Edwards to lead new market-focused organization
Apr 11, 2024
Prime Therapeutics and Magellan Rx present award-winning and industry-leading clinical insights at AMCP
Mar 13, 2024
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Dec 28, 2020
Notice of incorrect information sent to some Washington health plan members
Dec 22, 2020
Prime Therapeutics' predictive model expands efforts to reduce potential misuse and abuse of opioids
Dec 16, 2020
Prime Therapeutics and Takeda agree to outcomes-based arrangement for Hemophilia A treatment ADVATE® [Antihemophilic Factor (Recombinant)]
Oct 29, 2020
Blue Cross and Blue Shield of Nebraska, Prime Therapeutics provide free over-the-counter medicines, products to Medicare Advantage members
Oct 20, 2020
Study shows taking Entresto® as prescribed associated with lowering total cost of care by $6.7 million
Oct 19, 2020
Annual drug costs increased $1.25 billion for members with more than $250,000 in annual drug spend - doubling in four years
Oct 19, 2020
Lower total cost of care, hospitalizations, emergency visits associated with greater drug adherence among Medicare Advantage members
Sep 16, 2020
Prime Therapeutics Adds Rx Savings Solutions Tool to Bring Visibility to Prescription Drug Prices, Aims to Improve Consumer Experience
  •  
  • Page 1
  • ››

Latest News

Jul 30, 2025

Faraday Future to Present at the J.P. Morgan Auto Investor Conference in New York on August 12, 2025

Jul 30, 2025

RTX's Raytheon introduces advanced targeting system for U.S. Navy helicopters

Jul 30, 2025

Compass Minerals Announces Conference Call to Discuss Third-Quarter Fiscal 2025 Results

Jul 30, 2025

Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.115 per Common Limited Partner Unit

Jul 30, 2025

Excelerate Energy Raises FY 2025 Guidance and Reports Jamaica Acquisition Pro Forma Financial Results

Jul 30, 2025

Luminar Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Jul 30, 2025

Deswell Announces Filing and Availability of Annual Report on Form 20-F

Jul 30, 2025

Sturm, Ruger & Company, Inc. to Report Second Quarter Results and File Quarterly Report on Form 10-Q on...

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia